{"id":"https://openalex.org/W2005360196","doi":"https://doi.org/10.1248/bpb.b14-00711","title":"In Vitro Inhibition of CYP2C9-Mediated Warfarin 7-Hydroxylation by Iguratimod","display_name":"In Vitro Inhibition of CYP2C9-Mediated Warfarin 7-Hydroxylation by Iguratimod","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2005360196","doi":"https://doi.org/10.1248/bpb.b14-00711","mag":"2005360196","pmid":"https://pubmed.ncbi.nlm.nih.gov/25757926"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.b14-00711","doi":"https://doi.org/10.1248/bpb.b14-00711","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b14-00711","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/38/3/38_b14-00711/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/bpb/38/3/38_b14-00711/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029260015","display_name":"Satoshi Yamaori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Yamaori","raw_affiliation_strings":["Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University","Department of Pharmacy, Shinshu University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University","institution_ids":["https://openalex.org/I137975476"]},{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital","institution_ids":["https://openalex.org/I4210129652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051204394","display_name":"Ken Takami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ken Takami","raw_affiliation_strings":["School of Medicine, Shinshu University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Shinshu University","institution_ids":["https://openalex.org/I137975476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071769872","display_name":"Ayaka Shiozawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ayaka Shiozawa","raw_affiliation_strings":["Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University","Department of Pharmacy, Shinshu University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University","institution_ids":["https://openalex.org/I137975476"]},{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital","institution_ids":["https://openalex.org/I4210129652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080010429","display_name":"Kanako Sakuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kanako Sakuyama","raw_affiliation_strings":["Department of Pharmacy, Shinshu University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital","institution_ids":["https://openalex.org/I4210129652"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Naoki Matsuzawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoki Matsuzawa","raw_affiliation_strings":["Department of Pharmacy, Shinshu University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital","institution_ids":["https://openalex.org/I4210129652"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108751783","display_name":"Shigeru Ohmori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137975476","display_name":"Shinshu University","ror":"https://ror.org/0244rem06","country_code":"JP","type":"education","lineage":["https://openalex.org/I137975476"]},{"id":"https://openalex.org/I4210129652","display_name":"Shinshu University Hospital","ror":"https://ror.org/03a2hf118","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210129652"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Ohmori","raw_affiliation_strings":["Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University","Department of Pharmacy, Shinshu University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University","institution_ids":["https://openalex.org/I137975476"]},{"raw_affiliation_string":"Department of Pharmacy, Shinshu University Hospital","institution_ids":["https://openalex.org/I4210129652"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4034,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.76132019,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":"3","first_page":"441","last_page":"447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iguratimod","display_name":"iguratimod","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.8870000243186951},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.6779999732971191},{"id":"https://openalex.org/keywords/warfarin-metabolism","display_name":"warfarin metabolism","score":0.597000002861023},{"id":"https://openalex.org/keywords/s-warfarin","display_name":"S-warfarin","score":0.7450000047683716},{"id":"https://openalex.org/keywords/cyp2c9-1","display_name":"CYP2C9*1","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cyp2c9-3","display_name":"CYP2C9*3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/competitive-inhibition","display_name":"competitive inhibition","score":0.7979999780654907},{"id":"https://openalex.org/keywords/mixed-inhibition","display_name":"mixed-type inhibition","score":0.972000002861023},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.6949999928474426},{"id":"https://openalex.org/keywords/inhibition-kinetics","display_name":"inhibition kinetics","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C2781109383","wikidata":"https://www.wikidata.org/wiki/Q898497","display_name":"Hydroxylation","level":3,"score":0.7409422993659973},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6669121384620667},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.66230309009552},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.6278690099716187},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.616706371307373},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.6161584258079529},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36772826313972473},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.30969613790512085},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2627221345901489},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23201808333396912},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22658535838127136},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.22132357954978943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1412724256515503},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002867","descriptor_name":"Chromones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006900","descriptor_name":"Hydroxylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1248/bpb.b14-00711","doi":"https://doi.org/10.1248/bpb.b14-00711","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b14-00711","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/38/3/38_b14-00711/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:25757926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25757926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:00990:0002906283","doi":null,"is_oa":true,"landing_page_url":"https://soar-ir.repo.nii.ac.jp/records/20095","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BIOLOGICAL & PHARMACEUTICAL BULLETIN","raw_type":"journal article"},{"id":"pmh:oai:soar-ir.repo.nii.ac.jp:00020095","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10091/00020856","pdf_url":null,"source":{"id":"https://openalex.org/S4306402150","display_name":"SOAR (Shinshu University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I137975476","host_organization_name":"Shinshu University","host_organization_lineage":["https://openalex.org/I137975476"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"}],"best_oa_location":{"id":"doi:10.1248/bpb.b14-00711","doi":"https://doi.org/10.1248/bpb.b14-00711","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b14-00711","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/38/3/38_b14-00711/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1146439532","display_name":"Estimation of fetotoxicity of chemical compounds with human fetal liver cells and molecular basis of their toxicities","funder_award_id":"25460167","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005360196.pdf","grobid_xml":"https://content.openalex.org/works/W2005360196.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1971001793","https://openalex.org/W1974378218","https://openalex.org/W1987375927","https://openalex.org/W1999849541","https://openalex.org/W2009313893","https://openalex.org/W2018984407","https://openalex.org/W2021537502","https://openalex.org/W2032390387","https://openalex.org/W2037131718","https://openalex.org/W2044212672","https://openalex.org/W2065976317","https://openalex.org/W2070638340","https://openalex.org/W2096483010","https://openalex.org/W2141115118","https://openalex.org/W2147070133","https://openalex.org/W2163536623","https://openalex.org/W2401910378"],"related_works":["https://openalex.org/W2906306874","https://openalex.org/W2076670265","https://openalex.org/W3027896532","https://openalex.org/W4284711870","https://openalex.org/W2070638340","https://openalex.org/W2784246173","https://openalex.org/W2118546187","https://openalex.org/W2474832751","https://openalex.org/W1967783552","https://openalex.org/W4406478632"],"abstract_inverted_index":{"Iguratimod":[0,34,74,108,195],"is":[1,44,209],"a":[2,146,210],"novel":[3],"disease-modifying":[4],"antirheumatic":[5],"drug.":[6],"A":[7],"blue":[8],"letter":[9],"(safety":[10],"advisory)":[11],"for":[12,171,178,183],"drug":[13],"interaction":[14],"between":[15],"iguratimod":[16,48,61,133,167,208],"and":[17,27,70,96,143,154,173,186,191,218],"warfarin":[18,37,50,63,216],"was":[19,54,92,102,225],"issued":[20],"by":[21,40,106,166],"the":[22,58,111,135,161],"Ministry":[23],"of":[24,29,60,80,86,115,121,129,139,152,160,163,201,214],"Health,":[25],"Labour":[26],"Welfare":[28],"Japan":[30],"in":[31,145],"May":[32],"2013.":[33],"may":[35],"affect":[36],"metabolism":[38],"catalyzed":[39],"CYP.":[41],"However,":[42],"it":[43],"not":[45,197],"clear":[46],"whether":[47],"inhibits":[49],"oxidation.":[51],"This":[52],"study":[53],"performed":[55],"to":[56,98],"investigate":[57],"effects":[59],"on":[62,223,230],"7-hydroxylation":[64,165,217],"with":[65,82,94,117,149],"human":[66],"liver":[67],"microsomes":[68],"(HLMs)":[69],"recombinant":[71,140],"CYP":[72],"enzymes.":[73],"concentration-dependently":[75],"inhibited":[76,105,110,134],"R,S-warfarin":[77],"7-hydroxylase":[78,113,137],"activity":[79,114,138],"HLMs":[81,116,172],"an":[83,118],"IC50":[84,119,150],"value":[85,120],"15.2":[87],"\u00b5M.":[88],"The":[89,180],"inhibitory":[90,221],"effect":[91,222],"examined":[93],"S-warfarin":[95,112,136,164,202],"R-warfarin":[97,130],"determine":[99],"which":[100],"enantiomer":[101],"more":[103,226],"potently":[104,109],"iguratimod.":[107],"14.1":[122],"\u00b5M,":[123,156,193],"but":[124,175],"showed":[125],"only":[126],"slight":[127],"inhibition":[128,162,170,177,200],"7-hydroxylation.":[131,203],"Furthermore,":[132],"CYP2C9.1":[141,224],"(rCYP2C9.1)":[142],"rCYP2C9.3":[144,187],"concentration-dependent":[147],"manner":[148],"values":[151,182],"10.8":[153],"20.1":[155],"respectively.":[157,194],"Kinetic":[158],"analysis":[159],"indicated":[168,206],"competitive-type":[169],"rCYP2C9.1":[174],"mixed-type":[176],"rCYP2C9.3.":[179],"Ki":[181],"HLMs,":[184],"rCYP2C9.1,":[185],"were":[188],"6.74,":[189],"4.23,":[190],"14.2":[192],"did":[196],"exert":[198],"metabolism-dependent":[199],"These":[204],"results":[205],"that":[207,219,229],"potent":[211],"direct":[212],"inhibitor":[213],"CYP2C9-mediated":[215],"its":[220],"sensitive":[227],"than":[228],"CYP2C9.3.":[231]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}